Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01220687 · ClinicalTrials.gov registry record · NA

Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation

A NA study of Very Low Birth Weight Baby and Respiratory Distress Syndrome in Premature Infants, sponsored by University of Oklahoma.

Completed
Registry status
NA
Development phase
33
Enrollment target
2
Study locations

NCT01220687 is a NA study of Very Low Birth Weight Baby and Respiratory Distress Syndrome in Premature Infants that has completed, run by University of Oklahoma. The registered enrollment target is 33 participants. The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01220687, a NA study of Very Low Birth Weight Baby and Respiratory Distress Syndrome in Premature Infants, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
2
Study locations

Study Summary

This study hopes to determine whether nitric oxide along with oxygen during the first 20 minutes of life in infants needing help with breathing will reduce the percentage and total exposure to oxygen during that time frame. Although the use of oxygen in management of breathing is an important part of supporting baby immediately after delivery, there is more evidence that too much exposure to oxygen may lead to potential problems for your baby later. Oxygen exposure can be harmful to premature babies developing lungs.

Interventions

  • DRUG iNO
  • OTHER Nitrogen

Study Locations (2)

Oklahoma

  • University of Oklahoma Health Sciences Center - Oklahoma City
  • University of Oklahoma, Childrens Hospital - Oklahoma City

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2011-04
Est. Completion 2017-05-01
Phase NA

Sponsor

University of Oklahoma

358 total trials

What the Registry Record Tells You About NCT01220687

The ClinicalTrials.gov registry entry for NCT01220687 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Very Low Birth Weight Baby appearing as the primary indexed condition, and to 2 interventions - of which iNO is the first listed.

NCT01220687 reports 2 study locations spanning 1 distinct geographic area - top geographies include Oklahoma.

Frequently Asked Questions

What is clinical trial NCT01220687 about?

NCT01220687 is a clinical study titled "Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation". This study hopes to determine whether nitric oxide along with oxygen during the first 20 minutes of life in infants needing help with breathing will reduce the percentage and total exposure to oxygen during that time frame. Although the use of oxygen in management of breathing is an important part o...

What is the current status of trial NCT01220687?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2011-04. Estimated completion is 2017-05-01.

What conditions does trial NCT01220687 study?

This clinical trial studies the following conditions: Very Low Birth Weight Baby, Respiratory Distress Syndrome in Premature Infants.

What interventions are being tested in trial NCT01220687?

The interventions under investigation include: iNO (DRUG), Nitrogen (OTHER).

Who is sponsoring clinical trial NCT01220687?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01220687 being conducted?

This trial has 2 study locations across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Very Low Birth Weight Baby

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.